FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/20/2023
Back to search
Official data from USPTO
MEDSIR MEDICA SCIENTIA INNOVATION RESEARCH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
08/20/2023
Trademark type
Combined
Nice classes
42
Filing date
09/21/2021
Registration date
03/21/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/21/2023
Last transaction
03/21/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
87
Owner location
ES
Examiner
STADELI, MARTA
Law office
N50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "MEDSIR" centered over the stylized wording "MEDICA SCIENTIA INNOVATION RESEARCH" with "SIR" in orange font and the rest of the wording in black font, and to the left of the wording is a design consisting of twelve circles creating five diagonal lines with the first and fifth lines each consisting of two separate gray circles, the second and fourth lines each consisting of three orange connected circles, and the third line consisting of two gray connected circles.
Holders and representatives
Holders
MEDICA SCIENTIA INNOVATION RESEARCH, S.L.
Representatives
Jason L DeFrancesco DeFrancesco Lee LLC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientific and technological servicesscientific researchanalysis and testing in the field of oncology; medical and pharmacological research services; consultancy relating to laboratory testingconsultancy relating to scientific laboratory services; consultancy relating to research and development in the field of therapeutics; consultancy relating to pharmacology; consultancy relating to pharmaceutical research and development; development of pharmaceutical preparations and medicines; medical and scientific researchconducting clinical trials for others; clinical studiesclinical research in the field of oncology; evaluation of pharmaceutical products; scientific and medical research information regarding pharmaceutical products and clinical trials; biological researchclinical research in the field of oncologymedical research; scientific research for medical purposes in the field of oncology; medical research; scientific research and development; pharmaceutical drug development services; biomedical research services; pharmaceutical research services; laboratory research services relating to pharmaceuticals; medical research laboratory services; medical laboratory services; provision of information regarding results of clinical trials relating to pharmaceutical products
Publications
History of USPTO decisions and trademark events.
22 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
07/12/2023
XXCR
GENERIC MADRID TRANSACTION CREATED
07/12/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/21/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/21/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
03/21/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/03/2023
PUBO
PUBLISHED FOR OPPOSITION
01/03/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/14/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/30/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/02/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/02/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/02/2022
RFNP
REFUSAL PROCESSED BY IB
08/23/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/29/2022
RFRR
REFUSAL PROCESSED BY MPU
07/28/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/08/2022
CNRT
NON-FINAL ACTION WRITTEN
07/07/2022
DOCK
ASSIGNED TO EXAMINER
06/23/2022
MAFR
APPLICATION FILING RECEIPT MAILED
11/09/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/05/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/04/2021
Continuous trademark protection
Get notified about every new filing that threatens MEDSIR MEDICA SCIENTIA INNOVATION RESEARCH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.